tiprankstipranks
Takeda Pharmaceutical Co Ltd (JP:4502)
:4502
Japanese Market
4502
Takeda Pharmaceutical Co
RESEARCH TOOLSreports

Takeda Pharmaceutical Co (4502) Stock News & Sentiment

7 Followers
Takeda’s Oral Psoriasis Drug Zasocitinib Shows Strong Phase 3 Results
Premium
Company Announcements
Takeda’s Oral Psoriasis Drug Zasocitinib Shows Strong Phase 3 Results
10h ago
Takeda Sets June CEO Handover to Julie Kim and Overhauls Board Line-up
Premium
Company Announcements
Takeda Sets June CEO Handover to Julie Kim and Overhauls Board Line-up
4d ago
Takeda Unveils Cost-Saving Transformation to Fund Next Wave of Drug Launches
Premium
Company Announcements
Takeda Unveils Cost-Saving Transformation to Fund Next Wave of Drug Launches
5d ago
Takeda and Protagonist Win FDA Priority Review for First-in-Class Polycythemia Vera Drug
Premium
Company Announcements
Takeda and Protagonist Win FDA Priority Review for First-in-Class Polycythemia Vera Drug
28d ago
Takeda Wins FDA Priority Review for Potential First-in-Class Narcolepsy Drug
Premium
Company Announcements
Takeda Wins FDA Priority Review for Potential First-in-Class Narcolepsy Drug
2M ago
Takeda Posts Lower Nine-Month Revenue but Higher Profit, Lifts Dividend and Trims Growth Outlook
Premium
Company Announcements
Takeda Posts Lower Nine-Month Revenue but Higher Profit, Lifts Dividend and Trims Growth Outlook
2M ago
TKPHF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
TKPHF Upcoming Earnings Report: What to Expect?
2M ago
More JP:4502 News >

4502 News on the Web

Takeda's Zasocitinib Shows Rapid, Durable Skin Clearance In Phase 3 Psoriasis Trials
rttnews
Bullish
Takeda announces new data from Phase 3 studies of TAK-279
TipRanks News
Neutral
Takeda Sets June CEO Handover to Julie Kim and Overhauls Board Line-up
TipRanks News
Bullish
Takeda Unveils Cost-Saving Transformation to Fund Next Wave of Drug Launches
TipRanks News
Bullish
Alkermes price target lowered to $43 from $45 at Piper Sandler
TipRanks News
Neutral
Protagonist Therapeutics price target raised to $100 from $86 at Wedbush
TipRanks News
Neutral
Takeda, Protagonist announce FDA acceptance of rusfertide new drug application
TipRanks News
Bullish
Takeda and Protagonist Win FDA Priority Review for First-in-Class Polycythemia Vera Drug
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
JP:4502
Sector Average
Media Buzz
This Week5 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4502’s Media Buzz Sentiment?
5 articles about JP:4502 were published this week. In an average week, 1.25 articles are published.
    What is JP:4502’s weekly average amount of articles?
    In an average week, 1.25 articles about JP:4502 are published.
      What is JP:4502’s News Sentiment?
      100% of articles about JP:4502 were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        WXIBFWuxi Biologics (Cayman)
        KODKodiak Sciences
        SHTDYSinopharm Group Co
        640China Resources Pharmaceutical Group Ltd.
        RZLTRezolute
        Showing the stocks with the most bullish news sentiment over the past week